Home › NDC Lookup › Labelers › Celltrion, Inc

Celltrion, Inc NDCs and Package Codes

This page lists NDC package records associated with labeler code 32228 (Celltrion, Inc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

21
Package NDCs
13
Products
13
Active listings
0
Discontinued
3
Ingredients
0
Therapeutic classes
4
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
adalimumab-aaty 6
infliximab-dyyb 5
bevacizumab-adcd 2
By dosage form
INJECTION, SOLUTION 8
INJECTION, POWDER, LYOPHILIZED, FO... 3
LIQUID 1
INJECTION 1

Browse records — 13 products

Drug / product Billing NDC NADAC / unit Status
Adalimumab-aaty .9 kg/.9kg LIQUID CELLTRION, · NDC 32228-0021-01 · 4 BOTTLE in 1 BOX (32228-021-01) / .9 kg in 1 BOTTLE 32228-0021-01 — On market View →
adalimumab-aaty 80 mg/.8mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0010-01 · .8 mL in 1 SYRINGE (32228-010-01) 32228-0010-01 — On market View →
adalimumab-aaty 40 mg/.4mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0009-01 · .4 mL in 1 SYRINGE (32228-009-01) 32228-0009-01 — On market View →
adalimumab-aaty 20 mg/.2mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0006-01 · .2 mL in 1 SYRINGE (32228-006-01) 32228-0006-01 — On market View →
adalimumab-aaty 40 mg/.4mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0007-01 · .4 mL in 1 SYRINGE (32228-007-01) 32228-0007-01 — On market View →
adalimumab-aaty 80 mg/.8mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0008-01 · .8 mL in 1 SYRINGE (32228-008-01) 32228-0008-01 — On market View →
bevacizumab-adcd 400 mg/16mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0005-01 · 16 mL in 1 VIAL (32228-005-01) 32228-0005-01 — On market View →
bevacizumab-adcd 100 mg/4mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0020-01 · 4 mL in 1 VIAL (32228-020-01) 32228-0020-01 — On market View →
infliximab-dyyb 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLTRION, · NDC 32228-0001-01 · 750 VIAL, SINGLE-USE in 1 BOX (32228-001-01) / 10 mL in 1 VIAL, SINGLE-USE 32228-0001-01 — On market View →
infliximab-dyyb 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLTRION, · NDC 32228-0001-01 · 750 VIAL, SINGLE-USE in 1 BOX (32228-001-01) / 10 mL in 1 VIAL, SINGLE-USE 32228-0001-01 — On market View →
infliximab-dyyb 9 kg/9kg INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLTRION, · NDC 32228-0002-01 · 4 BOTTLE in 1 BOX (32228-002-01) / .9 kg in 1 BOTTLE 32228-0002-01 — On market View →
infliximab-dyyb 9 kg/9kg INJECTION CELLTRION, · NDC 32228-0022-01 · 4 BOTTLE in 1 BOX (32228-022-01) / .9 kg in 1 BOTTLE 32228-0022-01 — On market View →
infliximab-dyyb 120 mg/mL INJECTION, SOLUTION CELLTRION, · NDC 32228-0019-01 · 1 mL in 1 SYRINGE (32228-019-01) 32228-0019-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.